- Breaking News Related to Macular Degeneration, Cataract, Glaucoma, Corneal Disease and Other Eye Conditions - http://eyedocnews.com -

QLT Shows Positive 4 Week Efficacy in Phase II Study for Glaucoma Using Latanoprost Punctal Plug Delivery System

Posted By Dr. Ari Weitzner On August 30, 2011 @ 11:13 am In Glaucoma,Industry News,New Technologies | Comments Disabled

QLT Inc. yesterday announced results of its Phase II clinical study on the efficacy and safety of the Latanoprost Punctal Plug Delivery System (L-PPDS) in subjects with ocular hypertension (OH) and open-angle glaucoma (OAG).

The results were promising with the study representing the first reported demonstration of a clinically significant, prolonged (4 weeks) reduction in intraocular pressure (IOP) in glaucoma with an  extraocular, minimally-invasive sustained release ophthalmic drug delivery system.

Click here [1] for the full release.

Article printed from Breaking News Related to Macular Degeneration, Cataract, Glaucoma, Corneal Disease and Other Eye Conditions: http://eyedocnews.com

URL to article: http://eyedocnews.com/005956-qlt-drug-delivery-system-shows-promise/

URLs in this post:

[1] Click here: http://phoenix.corporate-ir.net/phoenix.zhtml?c=67181&p=irol-newsArticle&ID=1600946&highlight=

Copyright © 2008 Eye Doc Talk. All rights reserved.